Related Experiment Video
Updated: Feb 23, 2026
Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Management of KPC-producing Klebsiella pneumoniae infections
M Bassetti1, D R Giacobbe2, H Giamarellou3
1Infectious Diseases Clinic, Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy.
Background:
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic areas.
Aims:
To provide practical suggestion for physicians dealing with the management of KPC-KP infections in critically ill patients, based on expert opinions.
Sources:
PubMed search for relevant publications related to the management of KPC-KP infections.
Contents:
A panel of experts developed a list of 12 questions to be addressed. In view of the current lack of high-level evidence, they were asked to provide answers on the bases of their knowledge and experience in the field. The panel identified several key aspects to be addressed when dealing with KPC-KP in critically ill patients (preventing colonization in the patient, preventing infection in the colonized patient and colonization of his or her contacts, reducing mortality in the infected patient by rapidly diagnosing the causative agent and promptly adopting the best therapeutic strategy) and provided related suggestions that were based on the available observational literature and the experience of panel members.
Implications:
Diagnostic technologies could speed up the diagnosis of KPC-KP infections. Combination treatment should be preferred to monotherapy in cases of severe infections. For non-critically ill patients without severe infections, results from randomized clinical trials are needed for ultimately weighing benefits and costs of using combinations rather than monotherapy. Multifaceted infection control interventions are needed to decrease the rates of colonization and cross-transmission of KPC-KP.
Insights
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) is a critical pathogen. Expert opinion suggests combination therapy for severe infections and multifaceted infection control to reduce transmission.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) is a significant and growing global health threat.
- KPC-KP infections are particularly challenging in critically ill patients, demanding specialized management strategies.
Purpose of the Study:
- To offer practical guidance for physicians managing KPC-KP infections in critically ill patients.
- To consolidate expert opinions on key aspects of KPC-KP management, including prevention, diagnosis, and treatment.
Main Methods:
- A comprehensive PubMed search was conducted to gather relevant literature on KPC-KP infection management.
- A panel of experts addressed 12 key questions, drawing upon their knowledge, experience, and available observational data.
Main Results:
- Rapid diagnosis through advanced technologies can improve patient outcomes.
- Combination therapy is recommended over monotherapy for severe KPC-KP infections.
- Multifaceted infection control measures are essential to curb colonization and cross-transmission.
Conclusions:
- Further randomized clinical trials are necessary to define optimal treatment strategies for non-critically ill patients.
- Effective management of KPC-KP requires a combination of rapid diagnostics, appropriate therapeutic choices, and robust infection control protocols.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:24Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Acute Respiratory Failure-III
01:28Chronic Kidney Disease III: Interprofessional Care
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...